A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: The emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil

International Journal of Health Geographics

Volumn 10, Issue , 2011, Pages

  Kiffer, Carlos R V ^a,e   Camargo, Eduardo C G ^b   Shimakura, Silvia E ^c   Ribeiro Jr, Paulo J ^c   Bailey, Trevor C ^d   Pignatari, Antonio C C ^a   Monteiro, Antonio M V ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO NACIONAL DE PESQUISAS ESPACIAIS   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d UNIVERSITY OF EXETER   (United Kingdom)

^e GC 2 Pharmaceutical Research and Development Llc   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; DIGITAL MAP; EPIDEMIOLOGY; GIS; INFECTIOUS DISEASE; MEDICAL GEOGRAPHY; RISK FACTOR; SPATIAL ANALYSIS; SPATIAL VARIATION; STOCHASTICITY;

BRAZIL; SAO PAULO [BRAZIL];

ESCHERICHIA COLI;

CIPROFLOXACIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BRAZIL; COMPARATIVE STUDY; DEMOGRAPHY; DRUG EFFECT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; ETHNOLOGY; FEMALE; HUMAN; LONGITUDINAL STUDY; PHYSIOLOGY; URBAN POPULATION;

BRAZIL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; LONGITUDINAL STUDIES; RESIDENCE CHARACTERISTICS; URBAN POPULATION;

EID: 79952045833     PISSN: None     EISSN: 1476072X     Source Type: Journal    
DOI: 10.1186/1476-072X-10-17     Document Type: Article

References (33)

1. World Health Organization Department of Communicable Disease Surveillance and Response. WHO Global Strategy for Containment of Antimicrobial Resistance (WHO/CDS/CSR/DRS/2001.2). 2001, 1-96. WHO, Switzerland, World Health Organization.
2. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year?. Lancet 2003, 361:2226-2234. 10.1016/S0140-6736(03)13779-8, 12842379.
3. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: A population perspective. Emerging Infectious Diseases 2002, 8:347-354. 10.3201/eid0804.010312, 2730242, 11971765.
4. Infectious Diseases Society of America Bad bugs, no drugs, as antibiotic discovery stagnates, a public health crisis brews. Infectious Diseases Society of America., http://www.idsociety.org/BBNDWhitePaper04.htm
5. Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005, 11:794-801.
6. Woolhouse ME. Epidemiology: emerging diseases go global. Nature 2008, 451:898-899. 10.1038/451898a, 18288175.
7. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. Global trends in emerging infectious diseases. Nature 2008, 451:990-U994. 10.1038/nature06536, 18288193.
8. EUREQA: Epidemiologia do Uso e da Resistência de Antibióticos e Quimioterápicos na população. EUREQA Project, FAPESP Research Grant 2006/53922-9. , http://www.dpi.inpe.br/eureqa
9. Aldeyab MA, Monnet DL, Lopez-Lozano JM, Hughes CM, Scott MG, Kearney MP, Magee FA, McElnay JC. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. Journal of Antimicrobial Chemotherapy 2008, 62:593-600. 10.1093/jac/dkn198, 18467307.
10. Lopez-Lozano JM, Monnet DL, Yague A, Burgos A, Gonzalo N, Campillos P, Saez M. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. International Journal of Antimicrobial Agents 2000, 14:21-31. 10.1016/S0924-8579(99)00135-1, 10717497.
11. Cizman M. The use and resistance to antibiotics in the community. International Journal of Antimicrobial Agents 2003, 21:297-307. 10.1016/S0924-8579(02)00394-1, 12672574.
12. Livermore DM. Minimising antibiotic resistance. Lancet Infectious Diseases 2005, 5:450-459. 10.1016/S1473-3099(05)70166-3, 15978531.
13. WHO: Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health. , http://www.whocc.no/atcddd/
14. TerraView TerraView., http://www.dpi.inpe.br/terraview
15. Okabe A. Spatial tessellations: concepts and applications of Voronoi diagrams 2000, Chichester; New York: Wiley, 2.
16. Aurenhammer F. Voronoi Diagrams - a Survey of a Fundamental Geometric Data Structure. Computing Surveys 1991, 23:345-405.
17. Bowyer A. Computing Dirichlet Tessellations. Computer Journal 1981, 24:162-166.
18. Hastie T, Tibshirani R. Generalized Additive-Models - Some Applications. Journal of the American Statistical Association 1987, 82:371-386.
19. Hastie T, Tibshirani R. Generalized additive models 1990, London; New York: Chapman and Hall, 1.
20. Kelsall JE, Diggle PJ. Spatial variation in risk of disease: a nonparametric binary regression approach. Journal of the Royal Statistical Society Series C-Applied Statistics 1998, 47:559-573.
21. Diggle PJ. Statistical Analysis of Spatial Point Patterns 1983, Academic Press.
22. Hosmer DW, Lemeshow S. Applied logistic regression 1989, New York: Wiley.
23. Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: do international comparisons help?. Lancet Infect Dis 2001, 1:251-261. 10.1016/S1473-3099(01)00120-7, 11871512.
24. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001, 345:1007-1013. 10.1056/NEJMoa011265, 11586952.
25. Morten OAS, Dantas G, Church GM. Functional Characterization of the Antibiotic Resistance Reservoir in the Human Microflora. Science 2009, 325:1128. 10.1126/science.1176950, 19713526.
26. Hanage WP, Fraser C, Tang J, Connor TR, Corander J. Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science 2009, 324:1454-1457. 10.1126/science.1171908, 19520963.
27. Martinez JL. Antibiotics and antibiotic resistance genes in natural environments. Science 2008, 321:365-367. 10.1126/science.1159483, 18635792.
28. Tirabassi MV, Wadie G, Moriarty KP, Garb J, Konefal SH, Courtney RA, Sachs BF, Wait R. Geographic information system localization of community-acquired MRSA soft tissue abscesses. Journal of Pediatric Surgery 2005, 40:962-966. 10.1016/j.jpedsurg.2005.03.010, 15991178.
29. Vieira AR, Houe H, Wegener HC, Wong DMALF, Bodker R, Emborg HD. Spatial Scan Statistics to Assess Sampling Strategy of Antimicrobial Resistance Monitoring Program. Foodborne Pathogens and Disease 2009, 6:15-21. 10.1089/fpd.2008.0132, 18991541.
30. McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, Schaffner W, Reingold A, Hadler J, Cieslak P, et al. Geographic Diversity and Temporal Trends of Antimicrobial Resistance in Streptococcus pneumoniae in the United States. Nature Medicine 2003, 9:424-430. 10.1038/nm839, 12627227.
31. Stelling J, Yih WK, Galas M, Kulldorff M, Pichel M, Terragno R, Tuduri E, Espetxe S, Binsztein N, O'Brien TF, et al. Automated use of WHONET and SaTScan to detect outbreaks of Shigella spp. using antimicrobial resistance phenotypes. Epidemiology and Infection 2010, 138:873-883. 10.1017/S0950268809990884, 19796449.
32. Tacconelli E. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Current Opinion in Infectious Diseases 2009, 22:352-358. 10.1097/QCO.0b013e32832d52e0, 19461514.
33. Camara G, Vinhas L, Ferreira KR, Queiroz GR, Souza RCM, Monteiro AMV, Carvalho TM, Casanova MA, Freitas UM. TerraLib: An Open Source GIS Library for Large-scale Environmental and Socio-economic Applications. 2008, Berlin: Springer.